Related Experiment Video For ANRIL
Updated: Feb 28, 2026

Serum and Plasma Copy Number Detection Using Real-time PCR
Published on: December 15, 2017
Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian
Mohammad Taheri1, Farkhondeh Pouresmaeili2, Mir Davood Omrani1
1Urogenital Stem cell research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Aim:
Prostate cancer and benign prostate hyperplasia (BPH) are heterogeneous disorders with high prevalence among men. The antisense noncoding RNA in the INK4 locus codes for a long noncoding RNA whose participation in cancer has been elucidated.
Method:
We analyzed rs1333045, rs4977574, rs1333048 and rs10757278 genotypes from this locus in 125 prostate cancer patients, 125 BPH patients as well as 220 normal age-matched subjects by means of tetra-primer amplification refractory mutation system PCR method.
Results:
The rs1333045 showed no significant difference in allele or genotype frequencies between three groups. However, the other three single nucleotide polymorphisms have been shown to be associated with BPH and prostate cancer risk.
Conclusion:
Antisense noncoding RNA in the INK4 locus possibly participates in the pathogenesis of these disorders.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The Ras Gene
Ras is a...

